RecruitingNot ApplicableNCT07550140

ETASCAN Project: ETAS Project 2

The Impact of Chronic Consumption of ETAS® for 12 Weeks on Cognitive, Affective, and Neural Outcomes: A Randomised Parallel Group Placebo-controlled Study

Sponsor

University of Reading

Enrollment

60 participants

Start Date

May 5, 2026

Study Type

INTERVENTIONAL

Conditions

MRI Sleep Cognition Magnetic Resonance Spectroscopy fMRI Affect (Mental Function)

Summary

This study aims to investigate the chronic effects of ETAS® on cognitive, affective and neural outcomes in healthy adults aged 60-80 years with mild to moderate subjective cognitive complaints.

Eligibility

Min Age: 60 YearsMax Age: 80 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying ETAS® and Placebo for people with affect (mental function), cognition, and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include aged 60 Years to 80 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.